The IFN immune system plays an essential role in protecting the host against most viral infections. In order to explore the interactions between the IFN pathway and human respiratory syncytial virus (RSV) infection, and to identify potential IFN-stimulated genes (ISGs) that may be involved in suppressing the replication of RSV, we utilized an IFN pathway-specific microarray to study the effects of RSV infection on the IFN pathway in HeLa cells. We showed that RSV infection enhanced the expression of a series of ISGs, including oligoadenylate synthetase 2, IFITM1 (IFNinduced transmembrane protein 1) and myxovirus resistance 2. Our results also showed that the IFITM proteins potently inhibited RSV infection mainly by interfering with both virus entry and the subsequent replication steps, but not the attachment process. The antiviral effect of IFITM3 was not affected by ubiquitination modification. Furthermore, knocking down the endogenous and IFNinduced expression of IFITM1 and 3 facilitated RSV infection. Expression of the IFITM proteins was found to delay the phosphorylation of IFN regulatory factor 3 through interfering with the detection of viral RNA by MDA5 (melanoma differentiation-associated gene 5) and RIG-I (retinoic acid-inducible gene I). These results demonstrated that the restriction of RSV infection by the IFITM proteins was achieved through the inhibition of virus entry and replication, and they provided further insight for exploring the mechanism of IFITM-protein-mediated virus restriction.
INTRODUCTION
As the first line of defence against virus infection, the innate immune system in hosts utilizes multiple cellular receptors to discern different kinds of virus-specific factors (García-Sastre & Biron, 2006) . The recognition of viral infection further triggers downstream signalling pathways that ultimately lead to the production of type I IFNs (Sen, 2001) . Type I IFNs constitute a class of secretory cytokines that demonstrate multiple functions, including antiviral defence, antitumour activity, cell growth regulation and immunomodulation (Sadler & Williams, 2008) . Once synthesized and secreted, IFNs bind to IFN receptors present on the cell surface through autocrine or paracrine mechanisms and subsequently stimulate the Jak-STAT (Janus kinase-signal transducer and activator of transcription) signalling pathway, leading to the upregulation of hundreds of IFN-stimulated genes (ISGs). These ISGs set up an immune response against the invading pathogens (Jewell et al., 2007) . Only a few of the ISGs possessing a viral restriction function have been well characterized in terms of their antiviral mechanisms. These include the 29,59-OAS (29,59-oligoadenylate synthetase)/RNaseL system, protein kinase R and Mx (myxovirus resistance) genes (Sadler & Williams, 2008) . Recently, one family of ISGs, called IFN-inducible transmembrane (IFITM) proteins, and known to play diverse roles in cell signalling, adhesion, tumour genesis and immune regulation, was found to have the ability to restrict the cell entry and replication of a number of viruses. Most of the viruses restricted by the IFITM proteins are enveloped viruses, such as influenza A, dengue virus and West Nile virus (Brass et al., 2009; Weidner et al., 2010; Huang et al., 2011; Lu et al., 2011; Raychoudhuri et al., 2011; Mudhasani et al., 2013) , but reovirus, which is a non-enveloped dsRNA virus, was also recently reported to be sensitive to IFITM3 repression (Anafu et al., 2013) . IFITM3 has been reported to restrict cell infection of RSV and control disease pathogenesis in the Ifitm3 knockout mouse model (Everitt et al., 2013) . The complete nature of the antiviral mechanisms of the IFITM proteins has not been elucidated. Reports have demonstrated that IFITM proteins restrict virus infection independently of receptor usage, but occur in late endosomes or influence virus trafficking from endosomes to lysosomes to reduce virus infection indirectly (Diamond & Farzan, 2013) . IFITM3 was also shown to reduce the pathogenesis of influenza in mice and humans (Everitt et al., 2012) . Ubiquitination of IFITM3 can occur in both Lys48-linked and Lys63-linked polyubiquitin, and further impact the restriction effect of IFITM3 on influenza virus (Yount et al., 2012) .
Human respiratory syncytial virus (RSV) belongs to the family Paramyxoviridae and is an enveloped virus with a negative-sense ssRNA genome (McCarthy & Hall, 2003) . As a major viral cause of lower respiratory tract infection in infants and children worldwide, RSV infection often leads to mild, cold-like symptoms. Severe symptoms are usually restricted to the very young and elderly (Falsey et al., 1995; Handforth et al., 2000) . Currently, there is no effective vaccine against RSV infection. The ability of RSV to induce IFN was shown to be weak compared with that of other RNA viruses (Lo et al., 2005) . However, RSV was also found to induce high levels of IFN-a expression in different subsets of dendritic cells, and of IFN-b in cultures of various human respiratory epithelial cells and fibroblasts (Guerrero-Plata et al., 2005) . Thus, the roles of type I IFNs in RSV infection, and the interaction between RSV and the IFN pathway, are complex processes that have not been elucidated fully.
In this study, an IFN-a/b response PCR array analysis was utilized to study the effects of RSV infection on 84 genes related to the type I IFN pathway and it was shown that RSV infection elevated the expression of multiple ISGs. The potential antiviral effects of IFITM proteins on RSV were investigated and the results revealed that IFITM proteins could suppress RSV infection at an early stage after virus entry, with the replication process being the most probable main target of restriction. Furthermore, IFITM3 expression delayed the phosphorylation of IFN regulatory factor 3 (IRF3) caused by RSV infection. This study identified new ISGs that could restrict RSV infection and offered a direction for discovering the mechanisms of IFITM protein control of virus infection.
RESULTS

Type I IFNs inhibit RSV infection
The effects of type I IFNs on RSV infection were investigated by preincubating cells with different concentrations of type I IFNs followed by RSV infection. As shown in Fig. 1(a) , infection of RSV was partially repressed by low concentrations of IFNs (100 and 500 IU ml
21
) and the repression was increased with increasing levels of IFNs. At 2000 IU ml
, RSV was unable to replicate normally in both HeLa and Hep2 cells. However, Hep2 cells pretreated at the lower doses of IFNs produced less inhibitory effect than the corresponding HeLa cells (Fig. 1b) . These results showed that RSV replication was inhibited by type I IFN pretreatment in a dosage-dependent pattern.
When virus infection and IFN treatment were conducted simultaneously, the viral RNA levels showed that IFNs produced an inhibitory effect on RSV at nearly all concentrations of IFN-b used in both cell lines (Fig. 1c,  d ). However, compared with cells that were infected after IFN pretreatment, low doses of IFN-a2b produced lower inhibitory effects, but high doses still inhibited strongly. Similar to the pretreated cells, the restriction effect of IFNb was more pronounced than IFN-a2b at the same concentrations in both cell lines. These results suggested that cell infection accompanied by IFN treatment generally reduced the inhibitory effects of IFN. Next, an MTS [3-(4,5-dimethyl-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] cytotoxicity assay was performed to evaluate the potential cytotoxic effects of the IFNs on cells. The results indicated that IFNs had no obvious cytotoxic effects on cells (data not shown). These results suggested that the inhibitory effect of IFN treatment could be the result of certain ISGs induced by the IFN and functioning as antiviral proteins acting on RSV infection.
Effects of type I IFNs and RSV on the IFN pathway
An IFN-a/b response microarray analysis was conducted to obtain a comprehensive monitor of the changes of 84 type I IFN pathway-related genes upon IFN treatment and RSV infection in HeLa cells. All array data are listed in Table S1 (available in the online Supplementary Material).
The majority of genes detected were upregulated in the IFNtreated non-infection group as compared with the control group, with 10 out of the 84 genes showing significant changes, including several ISGs with known antiviral functions. Only SLC1A2 [solute carrier family 1 (glial high affinity glutamate transporter), member 2] was downregulated. In contrast, only a small number of genes were upregulated in cells infected with RSV alone. Interestingly, again only SLC1A2 was downregulated. This result indicated that RSV infection entailed certain repression effects on the IFN pathway (Fig. 2a , Table S1 ). The gene regulation pattern in IFN-pretreated RSV-infected cells was similar to that in the cells treated with IFN alone except for the downregulation of OAS2 and strong induction of STAT1 (Fig. 2b , Table S1 ). Compared with IFN-treated cells, the upregulation of genes induced by IFN (IFN-treated group compared with control group) was mostly abolished in IFN-pretreated RSV-infected cells, with only STAT1 being enhanced (Fig.  2c , Table S1 ). The array results confirmed that several ISGs with well-known antiviral function could be regulated by IFN treatment and RSV infection, including the broadspectrum antiviral gene products OAS2 and IFITM1. The restriction effect of the OAS family on RSV replication was reported previously (Lin et al., 2009) . Thus, the IFITM family was selected here for further studies.
Induction of IFN-induced Ifitm gene expression by RSV
The effects of RSV infection on Ifitm genes was further explored in HeLa and Hep2 cells. Consistent with the array results, mRNA levels of Ifitm1 and Ifitm2/3 increased upon IFN treatment in both cell lines (Fig. 3a, b) . RSV infection without IFN treatment also enhanced the mRNA of Ifitm1 and Ifitm2/3 compared with those in mock-infected control cells in both cell types (Fig. 3a, b) . The protein level of IFITM1 increased significantly upon RSV infection and IFN treatment, whereas levels of IFITM2/3 showed no obvious change due to the basal high levels of both proteins in HeLa (Fig. 3c) and Hep2 (Fig. 3d) cells. The influence of RSV infection on IFITM protein expression was examined by immunofluorescence in HeLa cells, which confirmed the significant upregulation of IFITM1 expression induced by RSV infection, whilst IFITM2/3 displayed a slight increase upon RSV infection (Fig. 3e) . These results demonstrated that RSV infection enhanced the status of IFITM protein expression.
IFITM proteins suppress RSV infection
Based on these results, the restriction effect of IFITM proteins on RSV infection was explored further. To this end, cells were transfected to express IFITM1, 2 or 3 followed by RSV infection. Quantitative real-time (qRT)-PCR results demonstrated that transient expression of IFITM proteins was significantly inhibited on RSV infection in both HeLa and Hep2 cells, suggesting that the inhibitory effect observed was independent of cell type. At both m.o.i. tested, the restriction effect of IFITM proteins on RSV was similar in HeLa cells, whereas increasing the viral load weakened the restriction effect of all IFITM proteins in Hep2 cells ( Fig. 4a-d) . To confirm the inhibition effects and facilitate further work on exploring the anti-RSV mechanism of IFITM proteins, doxycyclineinducible IFITM-protein-expressing HeLa cell lines were established (Fig. 4e) . The inhibition of RSV infection by IFITM proteins was verified by flow cytometry. All of the IFITM proteins shifted the mean fluorescence intensity peak to the left, which indicated the percentage of RSVpositive cells decreased compared with the control group (Fig. 4f) . Thus, these data suggested that expression of IFITM1, 2 or 3 could suppress RSV infection.
Restriction of RSV entry and replication by IFITM proteins
To further study which stages of the RSV life cycle were affected by IFITM proteins, we focused first on the attachment process. The qRT-PCR results demonstrated that there was no significant difference in the amount of virus RNA between control and IFITM-overexpressing cells (Fig. 5a) . Thus, the attachment of RSV to cells could not be inhibited by IFITM proteins. Next, the entry process was STAT2  TAP1  TNFSF10  TRAF3  VEGFA   HOXB2  CBFB  RCBTB1  SLC1A2  ATF5  NPEPPS  ITIH2  PRKRA  HLA-C  TRAF3  GCH1  CXCL10  IFNA1  IRF1  NRG1  CAV1  CNP  IFNAR1  ANXA11  IFNB1  ARL5A  ARL5B  PTTG1  CDKN1B  BAG3  IRF5  IFI30  IRF2  STAT2  HSPA1L  OAS2  ADAR  MNT  IFI6  IFI27  MX2  PSME2  STAT1  GBP1  IFITM1  OAS1  EIF2AK2  HLA-F  TNFSF10  IRF7  HLA-DOA  HLA-DQA1  IFNA2  IFNA4  MAL  SAMSN1  SH2D1A  HLA-A  TAP1  HLA-B  DIABLO  GBP2  HLA-E  CD70  DAD1  PML  PRKCZ  IFIT3  VEGFA  IFITM2  SHFM1  HLA-G  IFNAR2  MX1  IRF9  ISG20  NMI  IFI16  SHB  BST2  ISG15  CASP1  DNAJB2  MET  IFIT1  MYD88  IFIH1 Table S1 .
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On: Wed, 02 Jan 2019 17:33:12 (Fig. 5b) . These results indicated that the entry of RSV was partially repressed by IFITM3. When cells were infected by RSV (m.o.i. 1) for 2 h prior to the induction of IFITM proteins for another 24 h to bypass the entry process, the amounts of RSV viral RNA were still evidently affected by all of the induced IFITM proteins (Fig. 5c ). However, the inhibition effect was weakened compared with pre-expression of IFITM proteins (Fig. 4a) . These results indicated that the restriction effect of IFITM proteins likely targeted an early step in RSV infection.
To investigate whether the replication process was affected by IFITM proteins, a time-course experiment was performed. As shown in Fig. 5(d) , the replication of RSV started rapidly at 1 h p.i. with the peak beginning at 9 h p.i. All IFITM proteins demonstrated a strong repressive effect at the beginning of replication, which indicated that the inhibition pattern of IFITM proteins on RSV was rapid after infection. Amongst the three IFITM proteins, IFITM3-mediated restriction was more apparent than IFITM1 and 2. Therefore, it was suggested that IFITM proteins could inhibit RSV replication and target early events of the viral life cycle following viral internalization until viral replication, and the replication process was the main target.
Knockdown of IFITM proteins restores RSV infection
To confirm the restriction results of IFITM proteins on RSV infection, the effect of IFITM protein knockdown on RSV infection was investigated. Cells stably transfected with small hairpin RNA (shRNA) targeting IFITM1 and 3 significantly reduced the expression of these proteins with or without IFN treatment, whilst shRNA targeting IFITM2 had no obvious knockdown effect (Fig. 6a) . Each knockdown cell line was infected with RSV, and the qRT-PCR results showed that RSV infection was enhanced in IFITM3-depleted cells by 4.5-fold but in IFITM1-depleted HeLa cells had no obvious impact as only a 10 % increase of viral load was observed, which might have been due to the low basal level of IFITM1 in HeLa cells. Knockdown of the basal level of IFITM2 had no effect on RSV replication (Fig. 6b) . When knockdown cell lines were pretreated with IFN-b for 24 h prior to RSV infection, the results showed that IFITM3 knockdown resulted in~5.5-fold increase of RSV viral load and the increase of RSV was extended to 12.5-fold in IFITM1-depleted cells. However, the shRNA targeting IFITM2 only increased replication of RSV slightly (Fig. 6c) . Collectively, these results suggested that downregulating the expression of IFITM proteins, especially IFITM1 and 3, permitted the enhancement of RSV infection, and the inhibition of replication by type I IFNs was due in part to an increase in the expression of IFITM proteins.
Impact of ubiquitination on anti-RSV activity of IFITM3
As the ubiquitination modification impacts the restriction effect of IFITM3 on influenza virus, ubiquitin points of IFITM3 were mutated and the impact on RSV replication was investigated. The complete loss of ubiquitinated bands was achieved when all four lysine residues (Lys24, Lys83, Lys88 and Lys104) were mutated to alanine (UbDIFITM3); however, the protein level of ubiquitination-deficient IFITM3 was not increased compared with WT IFITM3 (Fig. 7a, b) , which indicated ubiquitination of IFITM3 did not promote the degradation of proteins. The influence of ubiquitination on the anti-RSV activity of IFITM3 was investigated. Expression of both WT and UbDIFITM3 resulted in an apparent reduction of RSV infection; however, the restriction effects of WT and UbDIFITM3 were similar at both m.o.i. and in both cell lines (Fig. 7c,  d ). These results suggested that ubiquitination on IFITM3 affected neither the protein stability nor its anti-RSV function.
IFITM3 delays the phosphorylation of IRF3 upon RSV infection
The RLR [RIG-I (retinoic acid-inducible gene I)-like receptor] pathway, characterized by the cytoplasmic receptors RIG-I and MDA5 (melanoma differentiationassociated gene 5), plays significant roles in defending against RSV infection (Aaron et al., 2012; Ling et al., 2009) . Could obstruction by IFITM proteins on RSV further delay the whole infection cycle of RSV, and reduce the probability of RSV RNA contact with MDA5 and RIG-I receptors? As shown in Fig. 8(a) , RSV infection induced the phosphorylation of IRF3 in HeLa cells. The increased phosphorylation level began at 6 h in the control group, but was delayed to 8 h upon IFITM3 overexpression. The results indicated that IRF3 phosphorylation induced by RSV infection was delayed by IFITM3 expression. Next, the viral RNA captured by MDA5 and RIG-I after RSV infection was investigated. As shown in Fig. 8(b, c) of Western blotting (Fig. 8d) indicated expression of IFITM3, MDA5 and RIG-I in the immunoprecipitates and inputs. These results demonstrated that IFITM3 hindered virus RNA detected by receptors, which further contributed to postponing IRF3 phosphorylation after RSV infection. 
DISCUSSION
In this study, an IFN-a/b response microarray analysis demonstrated that IFN treatment and RSV infection in HeLa cells could stimulate expression of multiple ISGs by different degrees, which could explain the sensitivity of RSV to IFN pretreatment. The IFITM protein family was chosen, and its profound restriction effects on RSV entry and replication were discovered. IFITM proteins were expressed ubiquitously in both the membrane and cytoplasm in many tissue and cell types, and were strongly induced by type I IFNs (Lu et al., 2011) . Compared with other viruses inhibited by IFITM proteins, the restriction of RSV was more profound than for human immunodeficiency virus, hepatitis C virus and influenza virus A at the same m.o.i. (Huang et al., 2011; Lu et al., 2011; Raychoudhuri et al., 2011) . However, Rift Valley fever virus infection also displayed intensive inhibition by IFITM3 (Mudhasani et al., 2013) . The different replication properties and IFN sensitivity of these viruses might contribute to their different sensitivity to the resistance of IFITM proteins. The knockdown results confirmed the vital role of IFITM proteins on the IFN-mediated antiviral effect and also suggested that other ISGs might participate in the restriction of IFNs in RSV infection. Therefore, IFITM inhibition might be important under natural infection conditions in hosts.
The restriction effect of IFITM proteins on RSV was not associated with the attachment process, which is consistent with the results from multiple other viruses restricted by IFITM proteins (Weidner et al., 2010; Raychoudhuri et al., 2011) . Previous antiviral research on IFITM proteins also demonstrated that the entry processes of most viruses were sensitive to IFITM proteins, which indicated a similar antiviral role was utilized by IFITM proteins. However, IFITM1 restricted HIV replication without affecting viral entry (Lu et al., 2011) . Recent studies indicated that IFITM3 localized to endosomes and lysosomes, leading to alterations in the endosomal compartments, including increased association with clathrin -an important protein utilized by multiple viruses during virus endocytosis (Huang et al., 2011; Yount et al., 2012) . However, another report contradicted the results of clathrin-mediated endocytosis of RSV and demonstrated that RSV utilized an actin-dependent, clathrin-and pH-independent macropinocytosis process to enter cells (Krzyzaniak et al., 2013) . The clathrin-dependent manner utilized by RSV is consistent with the finding that the entry process of RSV was one of the targets of IFITM proteins (Kolokoltsov et al., 2007) . No direct evidence of IFITM proteins associated with macropinocytosis has been shown; however, both proteins have a direct association with Rab5, which indicates IFITM proteins may also have the ability to influence the macropinocytosis process of RSV (Yount et al., 2012; Krzyzaniak et al., 2013) . The deficiency in ubiquitination of IFITM3 enhanced antiviral activity against H1N1 influenza virus through its increased localization on endolysosomal compartments (Yount et al., 2012) . However, ubiquitination-deficient IFITM3 showed no enhancement in anti-RSV activity. One possible explanation for this phenomenon is that the ubiquitinated IFITM3 located on the endolysosomal compartments is sufficient for the restriction effect on RSV, so the enhancement of ubiquitin-deficient IFITM3 on endolysosomal compartments had no enhancement effect on the antiviral function (Hsu et al., 2010) .
A study on Rift Valley fever virus also proposed that IFITM proteins modulate the biology of the vesicular compartments to affect virus trafficking, which results in the inhibitory effect (Anafu et al., 2013) . Our results demonstrated that the phosphorylation of IRF3 was delayed, and viral RNA captured by MDA5 and RIG-I was also reduced upon IFITM3 expression. These results suggest that IFITM proteins imprison or sequester RSV in the endosomes, lysosomes or other membrane vesicular structures during the entry and endocytosis processes, which further delays the release or migration of viral RNA from the endocytosed vesicles into the cytoplasm or other membrane structures, where replication and immune recognition occurs. However, the impeditive effect of IFITM proteins could not totally explain the inhibition of RSV replication, because RSV infection that bypassed entry and endocytosis during natural infection before IFITM protein induction was also repressed by IFITM proteins. This indicated that other inhibitory mechanisms for the effect of IFITM proteins on the replication process of RSV also exist.
In summary, this study suggested that RSV infection has multiple functions on the type I IFN pathway, including the stimulation of many ISGs, and that this effect was partly due to IFITM proteins which displayed repression during the early stages of RSV infection. This study also discovered the stimulation delay effect on the RLR pathway by IFITM proteins during RSV infection. Further work will be done to explore the exact antiviral mechanism of IFITM proteins and determine whether other ISGs also contribute to type I IFN defence against RSV infection.
METHODS
Cells and virus propagation. HeLa and Hep2 cells were maintained in Dulbecco's minimal essential medium (Gibco/Life Technologies) supplemented with 10 % FBS (Life Technologies), 100 IU penicillin ml 21 , 100 mg streptomycin ml 21 (Life Technologies) and 5 % L-glutamine (Gibco/Life Technologies). RSV (ATCC VR-26) was prepared by infecting monolayers of HeLa cells and the virus titre was determined by TCID 50 .
Plasmids, antibodies and reagents. Ifitm genes were amplified from HeLa cells after induction by IFN-a2b (1000 IU ml 21 ) for 6 h, and cloned into the pCMV-HA and pTre2-HA vectors. The ubiquitination-deficient HA-Ifitm3 was constructed using a Multipoints mutagenesis kit (TaKaRa). Rabbit anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and mouse anti-haemagglutinin (HA) antibodies were obtained from Sigma-Aldrich. Mouse anti-IFITM1, rabbit anti-IFITM2 and anti-IFITM3, rabbit anti-MDA5, rabbit anti-RIG-I, and rabbit anti-ubiquitin antibodies were all purchased from Proteintech. Rabbit anti-IRF3 and phosphorylated IRF3 (p-IRF3) antibodies were obtained from Cell Signaling Technology. Alexa Fluor 488-conjugated anti-mouse antibody, Alexa Fluor 594-conjugated antirabbit antibodies, and HRP-conjugated anti-rabbit and anti-mouse antibodies were all obtained from Santa Cruz Biotechnology. The anti-RSV G-protein antibody was purchased from Millipore. BSA was obtained from Becton Dickinson. Primer sequences used to amplify Ifitm1-3 are available upon request.
Evaluation of the cytotoxicity effect of type I IFNs by an MTSbased assay. Cells were grown in a 96-well plate and then incubated with various amounts of IFNs for 24 h, followed by incubation with the MTS labelling reagent for 4 h (CellTiter 96 AQueous One Solution Cell Proliferation Assay; Promega). The absorbance of the soluble formazan was measured at 490 nm.
RNA extraction and qRT-PCR. Cellular and viral RNAs were isolated using TRIzol reagent (Life Technologies). Total RNA (1 mg) was reverse transcribed with a GoScript Reverse Transcriptase kit (Promega). Two-step qRT-PCR was performed in a SYBR Green assay using an Applied Biosystems Master Mix reagents kit in an ABI 7300 Real-Time PCR system. GAPDH was used as the internal control. All experiments were performed using the following amplification profile: one cycle at 95 uC for 10 min, 40 cycles of 95 uC for 15 s and one cycle at 60 uC for 1 min. Primer sequences used in qRT-PCR are available upon request.
Evaluation of IFN treatment and RSV infection by IFN PCR
array. HeLa cells were divided into four groups and differentially treated with IFNs and/or RSV (type I IFN-treated group, RSVinfected group, IFN pretreated followed by RSV infection group and mock control group). The total RNA of HeLa cells was extracted 72 h p.i. using an RNeasy Mini kit (Qiagen) and then treated with RNaseFree DNase (Qiagen) to remove genomic DNA. Reverse transcription using 1 mg total RNA was performed using an RT 2 First Strand kit (Qiagen). Then, a human IFN-a/b response RT 2 Profiler PCR array (SuperArray Bioscience) analysis based on the qRT-PCR method was performed on the ABI 7300 system to analyse the relative expression of 84 key genes involved in the IFN pathway. Data were analysed using the 2 -DDCt method and the SABiosciences RT 2 Profiler PCR Array Data Analysis online software. The fold changes of various treatments were compared as described in Table S1 .
Western blotting analysis. Whole-cell extracts were prepared from cells lysed with lysis buffer containing 50 mM Tris/HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.25 % sodium deoxycholate, 1 % Triton X-100 and Complete Protease Inhibitor Cocktail Tablets (Roche). Cell extracts were subjected to 12 % SDS-PAGE, transferred to PVDF membranes (GE) followed by blocking with Tris-buffered saline/Tween 20 containing 5 % skimmed milk and then probed with the indicated primary antibody at different dilutions. After three washes, membranes were incubated with 1 : 5000 HRP-conjugated secondary antibody. The proteins were detected using ECL (GE) reagent. Establishment of stable cell lines. To establish the doxycyclineinducing IFITM1-3 stable cell lines, HeLa cells were transfected with pTet plasmid using Lipofectamine LTX reagent (Life Technologies) and selected under G418 (400 mg ml
21
) to generate the HeLa-pTet cell lines. Next, each of the HA-tagged IFITM1-3 plasmids, combined with the companion plasmid pTK-Hyg (Clontech) at a ratio of 10 : 1, was transfected into the HeLa-pTet cell lines and selected under hygromycin (200 mg ml 21 ) and G418 (400 mg ml 21 ). Then, the cell lines were exposed to doxycycline (1 mg ml 21 ) for 24 h followed by Western blotting with anti-HA antibody to detect the expression of IFITM proteins. IFITM protein knockdown cell lines were established by transfecting cells with shRNA plasmids (OriGene) targeting each of the Ifitm1-3 genes and then selected under puromycin (4 mg ml 21 ) for 2 weeks. The knockdown efficiency was verified by Western blotting. The sequences of the shRNA targeting Ifitm1-3 and control shRNA were: shRNA-IFITM1, TGCACAAGGAGGAACATGAGGT-GGCTGTG; shRNA-IFITM2, CCGCAGCGAGACCTCCGTGCCTG-ACCATG; shRNA-IFITM3, TCCTCATGACCATTCTGCTCATCGT-CATC; and shRNA-control, GCACTACCAGAGCTAACTCAGATA-GTACT.
Evaluation of the inhibitory effect of IFITM on RSV infection using flow cytometry. HeLa cells were transduced with doxycycline (1 mg ml Immunoprecipitation experiments. HeLa cell lines were transduced to express IFITM3 for 24 h and infected by RSV (m.o.i. 1). For immunoprecipitation of endogenous MDA5 and RIG-I, cells were collected and lysed in lysis buffer containing 40 U RNase inhibitor ml 21 (Promega) for protein extraction at 2, 6, 12 and 24 h p.i. The cell extracts were precleared with protein A/G Sepharose beads (Sigma-Aldrich) for 2 h in the presence of 1 mg rabbit IgG and 0.05 % BSA. Then, the supernatants were incubated with 0.1 mg anti-MDA5 or anti-RIG-I antibodies or rabbit IgG for 6 h at 4 uC followed by incubation with protein A/G beads for 1 h. Beads were washed three times with lysis buffer, and an aliquot was eluted in SDS sample buffer for Western blotting analysis to detect the expression of MDA5 and RIG-I. The remaining beads were incubated with 50 mg proteinase K (Sigma-Aldrich) for 30 min at 37 uC. Co-precipitated viral RNA adsorbed on MDA5 or RIG-I proteins was extracted by TRIzol reagent, and RSV viral load was determined by qRT-PCR. For immunoprecipitation of endogenous p-IRF3, cells infected with RSV were collected and lysed. Endogenous p-IRF3 was immunoprecipitated with 0.1 mg p-IRF3 antibody followed by absorption on protein A/G beads for 6 h at 4 uC. Western blotting was utilized to detect p-IRF3 levels. For immunoprecipitation of ubiquitinated IFITM3, cells were transfected with HA-tagged WT IFITM3 and ubiquitination-deficient IFITM3 (UbDIFITM3) for 24 h, cell extracts were incubated with anti-HA agarose (Sigma) for 6 h at 4 uC, and Western blotting was performed using anti-HA and anti-ubiquitin antibodies.
Statistical analysis. Measurements were compared using a one-way ANOVA. Statistical significance comparisons were calculated using Student's t-test. Values were considered statistically significantly different at P,0.05. Data from all experiments are presented as the mean±SEM.
